Cancer Reagents / Chemotherapy

HuHD provides reagents and tests ( manufacturedd by AmoyDx) that focuses on activating mutations in the EGFR pathway and chemotherapy response. The assays are based on a proprietary real-time PCR technology called “ADx-ARMS”. They have outstanding sensitivity (1%) and accuracy (99%). Three key tests – for mutations in the EGFR, KRAS and BRAF genes - have received both CE declarations for marketing in Europe and SFDA approval for clinical use in China.

HuHD is a distributor of AmoyDX products in the US.

HuHD is proud to offer the following cancer mutation kits and cancer detection kits:

Chemotherapy, Cancer, Mutation